Eternity Healthcare (OTCMKTS:ETAH) vs. Ginkgo Bioworks (NYSE:DNA) Head-To-Head Review

Ginkgo Bioworks (NYSE:DNA) and Eternity Healthcare (OTCMKTS:ETAH) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk and profitability.

Institutional & Insider Ownership

78.6% of Ginkgo Bioworks shares are held by institutional investors. 12.7% of Ginkgo Bioworks shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and target prices for Ginkgo Bioworks and Eternity Healthcare, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ginkgo Bioworks	2	2	0	0	1.50
Eternity Healthcare	0	0	0	0	0.00

Ginkgo Bioworks currently has a consensus target price of $6.33, suggesting a potential downside of 6.57%. Given Eternity Healthcare’s higher possible upside, analysts clearly believe Eternity Healthcare is more favorable than Ginkgo Bioworks.

Valuation and Earnings

This table compares Ginkgo Bioworks and Eternity Healthcare”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ginkgo Bioworks	$132.42 million	3.45	-$312.76 million	($5.01)	-1.35
Eternity Healthcare	N/A	N/A	N/A	N/A	N/A

Eternity Healthcare has lower revenue, but higher earnings than Ginkgo Bioworks.

Profitability

This table compares Ginkgo Bioworks and Eternity Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ginkgo Bioworks	-259.96%	-60.27%	-26.88%
Eternity Healthcare	N/A	N/A	N/A

About Ginkgo Bioworks

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

About Eternity Healthcare

Eternity Healthcare, Inc. engages in the provision of stem cell storage and related medical therapies in China. Its services include cell derivation and cell banking. The company was founded on October 24, 2007 and is headquartered in Hong Kong.